Sign in to view content

Evaluating Intravitreal ANX007, a Novel C1q Inhibitor, in the Treatment of GA Secondary to AMD: The ARCHER Study

David S. Boyer, MD

Video
Published 2021

Related

Outcomes of the HORNBILL Study: A Phase I/IIa Trial Investigating BI 764524 in Patients With Diabetic Macular Ischemia
Quan Dong Nguyen, MD, MSc, FARVO, FASRS
Updates from the Field
2024
Episode 19: LEAD Trial for Use of Nanopulse Laser for Dry AMD with Dr. Robyn Guymer
Keyvan Koushan, MD, FRCSC
Member Podcasts
2018
Combined Hamartoma of the Retina and Retinal Pigment Epithelium at Pediatric Age: Surgical vs Conservative Treatment: A Retrospective Multicenter Study
Sengul Ozdek, MD, FEBO, FASRS
On Demand Cases, Courses, and Papers
2021

Category: AMD-Non-Neovascular

See more